NEW YORK (GenomeWeb News) — Sequenom today said it has exclusively licensed IP to a non-invasive prenatal genetic analysis technology from the Chinese University of Hong Kong.
 
Under the agreement, Sequenom may use the school’s methylation marker and gene expression-analysis IP for fetal nucleic acids in North America, Europe, Australia, and Japan. It also received non-exclusive rights in China.
 
Sequenom also said the deal includes rights to some methylation and nucleic acid markers.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.